Published in Genes Dev on October 08, 2013
BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia. Mol Cell (2015) 1.36
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet (2016) 1.07
The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma. Elife (2015) 1.03
The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype. Mol Cell (2014) 1.00
Suppression of TET1-dependent DNA demethylation is essential for KRAS-mediated transformation. Cell Rep (2014) 0.92
PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus-Induced Liver Carcinogenesis. Cancer Res (2015) 0.91
3'LIFE: a functional assay to detect miRNA targets in high-throughput. Nucleic Acids Res (2014) 0.89
Is DNA methylation of tumour suppressor genes epigenetic? Elife (2014) 0.83
A long non-coding RNA targets microRNA miR-34a to regulate colon cancer stem cell asymmetric division. Elife (2016) 0.80
Ras Oncogene-Mediated Progressive Silencing of Extracellular Superoxide Dismutase in Tumorigenesis. Biomed Res Int (2015) 0.78
KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine. Cancer Res (2015) 0.76
Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells. Cell Rep (2016) 0.75
Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis. Proc Natl Acad Sci U S A (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Cancer genome landscapes. Science (2013) 25.33
Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer (2003) 15.17
A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem (1994) 14.36
Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem (1998) 13.93
The Polycomb complex PRC2 and its mark in life. Nature (2011) 11.97
Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol (2010) 9.35
Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell (1997) 6.55
Multiple Ras functions can contribute to mammalian cell transformation. Cell (1995) 5.24
Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev (2002) 4.30
DNA methylation and cancer. Adv Genet (2010) 3.50
A continuum model for tumour suppression. Nature (2011) 3.48
An elaborate pathway required for Ras-mediated epigenetic silencing. Nature (2007) 3.47
On the use of the word 'epigenetic'. Curr Biol (2007) 3.21
The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets (2012) 2.55
The role of EZH2 in tumour progression. Br J Cancer (2011) 2.33
F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature (2009) 1.93
Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J (1999) 1.73
The polycomb group protein enhancer of zeste homolog 2 (EZH 2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype. Oncogene (2005) 1.73
Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. Cancer Res (2007) 1.70
DNA methyltransferases, DNA damage repair, and cancer. Adv Exp Med Biol (2013) 1.57
Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. Cell Death Differ (2003) 1.41
Targeting PDK1 in cancer. Curr Med Chem (2011) 1.38
MAP kinase pathways. Cold Spring Harb Perspect Biol (2012) 1.29
Epigenetic changes in tumor Fas levels determine immune escape and response to therapy. Cancer Cell (2002) 1.06
Molecular characterization and tissue distribution of a novel member of the S100 family of EF-hand proteins. Biochemistry (2001) 0.96
Regulation of Fas-mediated apoptosis by N-ras in melanoma. J Invest Dermatol (2002) 0.84
Transcriptional regulatory elements in the human genome. Annu Rev Genomics Hum Genet (2006) 7.18
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell (2008) 6.84
A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell (2005) 4.32
Identification of direct DAF-16 targets controlling longevity, metabolism and diapause by chromatin immunoprecipitation. Nat Genet (2005) 4.15
Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell (2002) 3.56
ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics (2010) 3.47
An elaborate pathway required for Ras-mediated epigenetic silencing. Nature (2007) 3.47
Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA (2004) 3.16
Arginine-serine-rich domains bound at splicing enhancers contact the branchpoint to promote prespliceosome assembly. Mol Cell (2004) 2.90
Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Mol Cell (2005) 2.85
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. J Clin Invest (2013) 2.77
Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature (2005) 2.42
U2AF homology motifs: protein recognition in the RRM world. Genes Dev (2004) 2.34
RS domains contact splicing signals and promote splicing by a common mechanism in yeast through humans. Genes Dev (2006) 2.25
Differential requirement of SAGA components for recruitment of TATA-box-binding protein to promoters in vivo. Mol Cell Biol (2002) 2.16
A pathway of sequential arginine-serine-rich domain-splicing signal interactions during mammalian spliceosome assembly. Mol Cell (2004) 2.11
In vivo target of a transcriptional activator revealed by fluorescence resonance energy transfer. Genes Dev (2004) 1.99
Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell (2012) 1.98
F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature (2009) 1.93
A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell (2010) 1.85
Structural basis for polypyrimidine tract recognition by the essential pre-mRNA splicing factor U2AF65. Mol Cell (2006) 1.83
RS domain-splicing signal interactions in splicing of U12-type and U2-type introns. Nat Struct Mol Biol (2007) 1.67
Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice. Nature (2010) 1.64
BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription. Blood (2011) 1.61
Identification of a protein, G0S2, that lacks Bcl-2 homology domains and interacts with and antagonizes Bcl-2. Cancer Res (2009) 1.61
Systematic analysis of essential yeast TAFs in genome-wide transcription and preinitiation complex assembly. EMBO J (2003) 1.59
A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications. Nat Med (2010) 1.55
Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders. Blood (2011) 1.53
HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs. PLoS Biol (2005) 1.50
Initiation of zebrafish haematopoiesis by the TATA-box-binding protein-related factor Trf3. Nature (2007) 1.47
Characterization of enhancer function from genome-wide analyses. Annu Rev Genomics Hum Genet (2012) 1.41
p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase. Science (2006) 1.40
Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome. J Mol Med (Berl) (2007) 1.40
TRF3, a TATA-box-binding protein-related factor, is vertebrate-specific and widely expressed. Proc Natl Acad Sci U S A (2003) 1.34
A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene. Genes Dev (2008) 1.33
Crystal structure of UAP56, a DExD/H-box protein involved in pre-mRNA splicing and mRNA export. Structure (2004) 1.33
Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression. Mol Cell (2009) 1.31
The U2AF35-related protein Urp contacts the 3' splice site to promote U12-type intron splicing and the second step of U2-type intron splicing. Genes Dev (2010) 1.26
Distinct activities of the DExD/H-box splicing factor hUAP56 facilitate stepwise assembly of the spliceosome. Genes Dev (2008) 1.25
Selective recruitment of TAFs by yeast upstream activating sequences. Implications for eukaryotic promoter structure. Curr Biol (2002) 1.25
Inhibition of apoptosis by ATFx: a novel role for a member of the ATF/CREB family of mammalian bZIP transcription factors. Genes Dev (2002) 1.24
A single polypyrimidine tract binding protein (PTB) binding site mediates splicing inhibition at mouse IgM exons M1 and M2. RNA (2004) 1.14
A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype. Elife (2014) 1.12
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells. Blood (2013) 1.12
The viral protein Apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53. Genes Dev (2004) 1.11
Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines. Mol Cancer Ther (2009) 1.10
Interaction of Gal4p with components of transcription machinery in vivo. Methods Enzymol (2003) 1.07
Transcription and signalling pathways involved in BCR-ABL-mediated misregulation of 24p3 and 24p3R. EMBO J (2009) 1.06
Selective interaction between Trf3 and Taf3 required for early development and hematopoiesis. Dev Dyn (2009) 1.04
Solution conformation and thermodynamic characteristics of RNA binding by the splicing factor U2AF65. J Biol Chem (2008) 1.03
miR-146a promotes the initiation and progression of melanoma by activating Notch signaling. Elife (2014) 1.02
Role for IGFBP7 in senescence induction by BRAF. Cell (2010) 1.01
Apoptin nucleocytoplasmic shuttling is required for cell type-specific localization, apoptosis, and recruitment of the anaphase-promoting complex/cyclosome to PML bodies. J Virol (2006) 1.00
Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation. Nat Commun (2013) 0.98
The anaphase promoting complex: a critical target for viral proteins and anti-cancer drugs. Cell Cycle (2005) 0.98
Non-canonical TAF complexes regulate active promoters in human embryonic stem cells. Elife (2012) 0.97
The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells. Nat Genet (2012) 0.97
Transcriptional program of apoptosis induction following interleukin 2 deprivation: identification of RC3, a calcium/calmodulin binding protein, as a novel proapoptotic factor. Mol Cell Biol (2003) 0.96
Redirecting retroviral tropism by insertion of short, nondisruptive peptide ligands into envelope. J Virol (2002) 0.96
Transcription factor ATF5 is required for terminal differentiation and survival of olfactory sensory neurons. Proc Natl Acad Sci U S A (2012) 0.93
Resistance to vemurafenib resulting from a novel mutation in the BRAFV600E kinase domain. Pigment Cell Melanoma Res (2013) 0.92
Irf3 polymorphism alters induction of interferon beta in response to Listeria monocytogenes infection. PLoS Genet (2007) 0.90
Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands. J Virol (2002) 0.89
Functional analysis of TFIID components using conditional mutants. Methods Enzymol (2003) 0.89
U2AF65 adapts to diverse pre-mRNA splice sites through conformational selection of specific and promiscuous RNA recognition motifs. Nucleic Acids Res (2013) 0.88
An activating transcription factor 5-mediated survival pathway as a target for cancer therapy? Oncotarget (2010) 0.88
A synthetic interaction screen identifies factors selectively required for proliferation and TERT transcription in p53-deficient human cancer cells. PLoS Genet (2012) 0.88
When enough is enough: genetic diseases associated with transcriptional derepression. Curr Opin Genet Dev (2004) 0.87
Group A streptococcal meningitis: case report and review of the literature. J Infect (2005) 0.86
A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys (2012) 0.85
Multiple apoptotic defects in hematopoietic cells from mice lacking lipocalin 24p3. J Biol Chem (2011) 0.84
Structure of phosphorylated SF1 bound to U2AF⁶⁵ in an essential splicing factor complex. Structure (2012) 0.84
MEN1 is a melanoma tumor suppressor that preserves genomic integrity by stimulating transcription of genes that promote homologous recombination-directed DNA repair. Mol Cell Biol (2013) 0.83
High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma. Genes Chromosomes Cancer (2013) 0.83
Senescence induction in human fibroblasts and hematopoietic progenitors by leukemogenic fusion proteins. Blood (2010) 0.83
Isolation of High-Molecular-Weight DNA Using Organic Solvents. Cold Spring Harb Protoc (2017) 0.83
GABP transcription factor is required for development of chronic myelogenous leukemia via its control of PRKD2. Proc Natl Acad Sci U S A (2013) 0.82
Transcriptional derepression as a cause of genetic diseases. Curr Opin Genet Dev (2003) 0.80
hnRNP A1 contacts exon 5 to promote exon 6 inclusion of apoptotic Fas gene. Apoptosis (2013) 0.80
SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA. Oncol Rep (2013) 0.80
Allele frequency differences of cytochrome P450 polymorphisms in a sample of New Zealand Māori. N Z Med J (2008) 0.79
Aberrant expression of the dendritic cell marker TNFAIP2 by the malignant cells of Hodgkin lymphoma and primary mediastinal large B-cell lymphoma distinguishes these tumor types from morphologically and phenotypically similar lymphomas. Am J Surg Pathol (2011) 0.79
Genome wide association analysis of a founder population identified TAF3 as a gene for MCHC in humans. PLoS One (2013) 0.78
Analysis of Gal4-directed transcription activation using Tra1 mutants selectively defective for interaction with Gal4. Proc Natl Acad Sci U S A (2012) 0.78
Polypyrimidine tract binding protein inhibits IgM pre-mRNA splicing by diverting U2 snRNA base-pairing away from the branch point. RNA (2014) 0.78
Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations. J Cutan Pathol (2009) 0.78
Genome-wide RNAi screening to identify regulators of oncogene-induced cellular senescence. Methods Mol Biol (2013) 0.77
Targeting a TAF to make muscle. Mol Cell (2008) 0.76
Preparation of Plasmid DNA by Alkaline Lysis with Sodium Dodecyl Sulfate: Minipreps. Cold Spring Harb Protoc (2016) 0.76
TRIMming down tumor suppressors in breast cancer. Cell Cycle (2015) 0.75
Induction of senescence in melanoma: thinking outside the cell. Pigment Cell Melanoma Res (2011) 0.75
Constitutive expression of SMAR1 confers susceptibility to Mycobacterium tuberculosis infection in a transgenic mouse model. Indian J Med Res (2015) 0.75
A 2-nt RNA enhancer on exon 11 promotes exon 11 inclusion of the Ron proto-oncogene. Oncol Rep (2013) 0.75
Isolating DNA from Gram-Negative Bacteria. Cold Spring Harb Protoc (2017) 0.75
Isolation of High-Molecular-Weight DNA from Mammalian Tissues Using Proteinase K and Phenol. Cold Spring Harb Protoc (2017) 0.75
Concentrating Nucleic Acids by Extraction with Butanol. Cold Spring Harb Protoc (2017) 0.75
Estimating the Concentration of DNA by Fluorometry Using Hoechst 33258. Cold Spring Harb Protoc (2017) 0.75
Fluorescence resonance energy transfer as a method for dissecting in vivo mechanisms of transcriptional activation. Biochem Soc Symp (2006) 0.75
Precipitation of DNA with Ethanol. Cold Spring Harb Protoc (2016) 0.75